BioAge Labs, Inc. — Form D

BioAge Labs, Inc. of RICHMOND, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-13. The offering totals $194.4M, of which $194.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-02-13
• Form: D
• Accession: 0001709941-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $194.4M
• Amount sold: $194.4M
• Minimum investment: $3
• Investors: 32
• Date of first sale: 2024-02-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-505095

Issuer

• Name: BioAge Labs, Inc.
• CIK: 0001709941
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1445A SOUTH 50TH STREET, RICHMOND, CA, 94804
• Phone: 510-806-1445

Officers, directors & promoters (9)

More

• CIK 1709941 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search